Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial.

Wunderink RG, Laterre PF, Francois B, Perrotin D, Artigas A, Vidal LO, Lobo SM, Juan JS, Hwang SC, Dugernier T, LaRosa S, Wittebole X, Dhainaut JF, Doig C, Mendelson MH, Zwingelstein C, Su G, Opal S; CAPTIVATE Trial Group.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1561-8. doi: 10.1164/rccm.201007-1167OC. Epub 2011 Feb 4.

PMID:
21297074
2.

Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization.

Walz JM, Avelar RL, Longtine KJ, Carter KL, Mermel LA, Heard SO; 5-FU Catheter Study Group.

Crit Care Med. 2010 Nov;38(11):2095-102. doi: 10.1097/CCM.0b013e3181f265ba.

PMID:
20711070
3.

Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial.

Dellinger RP, Tomayko JF, Angus DC, Opal S, Cupo MA, McDermott S, Ducher A, Calandra T, Cohen J; Lipid Infusion and Patient Outcomes in Sepsis (LIPOS) Investigators.

Crit Care Med. 2009 Nov;37(11):2929-38. doi: 10.1097/CCM.0b013e3181b0266c.

PMID:
19770753
4.

Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial.

Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, Restrepo MI, Auger WR, Schinner R; NASCENT Investigation Group.

JAMA. 2008 Aug 20;300(7):805-13. doi: 10.1001/jama.300.7.805.

PMID:
18714060

Supplemental Content

Loading ...
Write to the Help Desk